GlassScriptPhysician profile
Madison Alice Mik
NPI 1700547528
$1,741.29
in general payments reported to CMS, 2019-2025
21 companies · $1,741 in 2025
The $1,741 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $205.46 | 2025 | Kisunla, Mounjaro, Zepbound |
| Abbvie INC. | $204.35 | 2025 | |
| Novo Nordisk INC | $179.49 | 2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $168.53 | 2025 | Airsupra, Breztri |
| Axsome Therapeutics, INC. | $158.33 | 2025 | Auvelity, Symbravo |
| Pfizer INC. | $152.54 | 2025 | |
| Amgen INC. | $134.22 | 2025 | Repatha, Otezla, Evenity |
| Exact Sciences Corporation | $60.64 | 2025 | Cologuard Collection Kit |
| Eisai INC. | $59.28 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $54.16 | 2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $45.74 | 2025 | |
| Medtronic, INC. | $44.34 | 2025 | Inceptiv |
| Aimmune Therapeutics, INC. | $39.60 | 2025 | Zenpep |
| Glaxosmithkline, LLC. | $38.73 | 2025 | Shingrix, Arexvy |
| Astellas Pharma US INC | $37.22 | 2025 | Veozah |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $36.45 | 2025 | |
| Phathom Pharmaceuticals, INC. | $34.62 | 2025 | Voquezna |
| Globus Medical, INC. | $30.66 | 2025 | Senza |
| Edwards Lifesciences Corporation | $23.53 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $18.05 | 2025 | Eliquis |
| Dynavax Technologies Corporation | $15.35 | 2025 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Mik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.